A 12-week, randomized, double-blind, placebo-controlled human trial to evaluate of Amomum villosum extract and Atractylodes macrocephala-extract mixture on decrease of body fat

A 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Amomum villosum extract and Atractylodes macrocephala-extract mixture on decrease of body fat

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006779

Enrollment

120

Registered

2021-11-25

Start date

2020-06-15

Completion date

Unknown

Last updated

2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : •Amomum villosum extract group : 2 times a day, 1 tablet once for 12 weeks, or oral intake after lunch/dinner (1,000mg/day, 500mg/day as Amomum villosum extract) •Atractylodes m

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) A person whose BMI is 25-34.9 kg/m2, or whose body fat percentage is 25% for men and 30% or more for women at the time of screening test; 2) A person who has fully understood the detailed explanation of this clinical study, and then agrees to voluntarily decide to participate and observe the precautions.

Exclusion criteria

Exclusion criteria: (1) A person who has at least 10% weight change within three months before the screening test (2) A person who has clinically significant acute or chronic cardiovascular relationships, endocrine systems, immune systems, respiratory systems, hepatic biliary systems, kidneys and urinary systems, neuropsychiatric systems, musculoskeletal systems, inflammatory and hematoplasia, gastrointestinal diseases, etc. (3) A fasting implementer. (4) A person who has received an antipsychotic medication within three months before the screening test (5) A person who participates in another clinical study or plans to participate in the clinical study within three months before the screening test; (6) A person who is deemed unsuitable for the person in charge of testing to participate in research due to the results of medical examinations for diagnostic examinations and other reasons

Design outcomes

Primary

Measure	Time frame
Body Fat Volume through DEXA	—

Secondary

Measure	Time frame
body weight	—

Countries

Korea, Republic of

Contacts

Public ContactJung Han Lee

Wonkwang University. Iksan Korean Medicine Hospital

milpaso@wku.ac.kr+82-63-859-2807

Outcome results